What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
Edward A. Neuwelt spends much of his time researching Surgery, Blood–brain barrier, Chemotherapy, Radiation therapy and Central nervous system.
His research integrates issues of Cancer, Intraocular lymphoma and Pediatrics in his study of Surgery.
His Blood–brain barrier research is multidisciplinary, incorporating perspectives in Brain tumor, Cerebrospinal fluid, Pathology and Pharmacology.
His work deals with themes such as Percent Activity, Magnetic resonance imaging, Hexosaminidase and Iron oxide nanoparticles, which intersect with Pathology.
His Chemotherapy study combines topics in areas such as Survival rate, Methotrexate, Survival analysis and Toxicity.
His studies in Radiation therapy integrate themes in fields like Craniotomy, Central nervous system disease, Biopsy and Lymphoma.
His most cited work include:
- Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. (571 citations)
- Outwitting the Blood-Brain Barrier for Therapeutic Purposes: Osmotic Opening and Other Means (523 citations)
- Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma (482 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Pathology, Chemotherapy, Internal medicine, Blood–brain barrier and Pharmacology.
His Pathology research incorporates themes from Magnetic resonance imaging and Glioma.
His work focuses on many connections between Magnetic resonance imaging and other disciplines, such as Nuclear medicine, that overlap with his field of interest in Ferumoxytol.
His work carried out in the field of Chemotherapy brings together such families of science as Anesthesia and Radiation therapy.
His study looks at the intersection of Internal medicine and topics like Oncology with Survival analysis.
His Blood–brain barrier study integrates concerns from other disciplines, such as Neurotoxicity, Pharmacokinetics and Mannitol.
He most often published in these fields:
- Pathology (35.61%)
- Chemotherapy (31.56%)
- Internal medicine (29.64%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (29.64%)
- Cancer research (9.38%)
- Ferumoxytol (16.20%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Cancer research, Ferumoxytol, Oncology and Chemotherapy.
His Ferumoxytol research is under the purview of Magnetic resonance imaging.
Edward A. Neuwelt interconnects Survival analysis and Glioblastoma in the investigation of issues within Oncology.
The various areas that he examines in his Chemotherapy study include Choroidal neovascularization and Lymphoma.
His Adverse effect research integrates issues from Off-label use and Surgery.
As part of one scientific family, he deals mainly with the area of Central nervous system, narrowing it down to issues related to the Chemokine, and often Blood–brain barrier.
Between 2016 and 2021, his most popular works were:
- Current and potential imaging applications of ferumoxytol for magnetic resonance imaging (117 citations)
- Current and potential imaging applications of ferumoxytol for magnetic resonance imaging (117 citations)
- The translational significance of the neurovascular unit (116 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
Edward A. Neuwelt mainly investigates Internal medicine, Ferumoxytol, Neuroscience, Magnetic resonance imaging and CD20.
His Internal medicine study frequently draws connections between related disciplines such as Oncology.
His study in Ferumoxytol is interdisciplinary in nature, drawing from both Neuroradiology, Gadoteridol, Nuclear medicine, Blood pool and Receiver operating characteristic.
Edward A. Neuwelt works in the field of Neuroscience, namely Blood–brain barrier.
His Magnetic resonance imaging research includes themes of Impaired renal function and Contrast medium.
His Primary central nervous system lymphoma research is within the category of Chemotherapy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
